A phase I trial to investigate a single oral dose of SCY-078 in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2016
At a glance
- Drugs SCY 078 (Primary)
- Indications Aspergillosis; Candidiasis; Vulvovaginal candidiasis
- Focus Adverse reactions
- 23 Jun 2016 New trial record
- 20 Jun 2016 Interim sub-analysis (n=24) from this trial were presented at ASM Microbe 2016, according to a Scynexis media release.
- 20 Jun 2016 Interim sub-analysis (n=24) from this trial published in a Scynexis media release.